Skip to main content

Advertisement

Table 1 Demographics and Baseline Clinical Characteristics for Patients With and Without Daily Headache

From: Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study

Characteristic With Daily Headache (n = 138) Without Daily Headache (n = 503)
Age, mean (SD), y 42.5 (11.7) 43.3 (10.9)
 Min, max 18, 71 18, 72
Female, n (%) 100 (72.5) 447 (88.9)
Race, n (%)
 Caucasian 116 (84.1) 417 (82.9)
 Black or African American 7 (5.1) 32 (6.4)
 Asian 14 (10.1) 51 (10.1)
 Native Hawaiian or other Pacific Islander 1 (0.7) 2 (0.4)
 American Indian or Alaska Native 0 (0.0) 1 (0.2)
BMI, kg/m2, mean (SD) 28.0 (6.6) 27.5 (6.6)
Age of migraine onset, mean (SD), y 32.7 (14.7) 32.3 (13.6)
Time since onset of migraine, mean (SD), y 9.9 (10.7) 11.1 (11.3)
Family history of migraine, n (%) 79 (57.3) 325 (64.6)
Headache days at baseline, mean (SD) 28.0 (0.0) 20.3 (4.0)
Moderate/severe headache days at baseline, mean (SD) 24.1 (5.1) 16.4 (4.5)
Medication use at baseline, n (%)a
 Previously taken acute medications 136 (98.6) 499 (99.2)
 Previously taken preventive medications 114 (82.6) 413 (82.1)
  1. a Data based on safety population
  2. BMI body mass index